New Bone Grafting Technique in Paediatric Foot Surgery. Validation of Outcome Measures
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether artificial bone graft (ReproBone™) provides equally good results compared to autologous bone graft from the iliac crest and reduces postoperative pain.
To groups of patients (age 5-16) will be compared. One group randomized to autologous bone graft and the other group randomized to ReproBone™.
The evaluation will be based on pedobarography, Patient reported outcome assessment (Oxford Ankle Foot Questionnaire), pain (measured by visual analog scale) and radiographic stereo assay.
| Condition | Intervention |
|---|---|
|
Pes Planovalgus |
Device: ReproBone Procedure: calcaneal lengthening |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment |
| Official Title: | New Bone Grafting Technique in Paediatric Foot Surgery. Validation of Outcome Measures |
- Visual Analog Scale [ Time Frame: 12 hrs ] [ Designated as safety issue: No ]The pain will be assessed within the first 24 hrs
- Radiographic stereometric assay (RSA) [ Time Frame: The RSA will be taken at baseline and the final investigation at 12 months ] [ Designated as safety issue: Yes ]RSA wille be taken immediately postoperative, after 6 weeks, after 8 weeks, after 6 months and after 12 months. In this way the investigators will evaluate the healing progress and be able to assess eventual microluxation in the cuboideum relatively to calcaneus.
- Pedobarography [ Time Frame: preoperative, 6 months, 12 months ] [ Designated as safety issue: No ]Preoperative: The ambulatory examination prior to surgery. Pedobarography: The investigators use a pressure plate from Tekscan. The pressure of the patients feet is measures during stance and walking.
| Estimated Enrollment: | 30 |
| Study Start Date: | February 2013 |
| Estimated Study Completion Date: | January 2017 |
| Estimated Primary Completion Date: | January 2016 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: ReproBone
calcaneal lengthening
|
Device: ReproBone
Artificial bone graft is inserted as a wedge in the calcaneal lengthening osteotomy
Other Name: Hydroxy-apatite-tricalcium-phosphate
Procedure: calcaneal lengthening
Autologous bone graft is harvested from the iliac crest and inserted as a wedge in the calcaneal lengthening osteotomy
Other Name: Autologous bone graft
|
|
Active Comparator: Autologous bone graft
calcaneal lengthening
|
Procedure: calcaneal lengthening
Autologous bone graft is harvested from the iliac crest and inserted as a wedge in the calcaneal lengthening osteotomy
Other Name: Autologous bone graft
|
Detailed Description:
Study C: HA-β TCP (ReproBone™) vs. autologous iliac crest bone graft in a calcaneal lengthening osteotomy in children with hindfoot valgus. A clinical randomized controlled study with 12 months of follow-up.
Purpose. To investigate the clinical and radiographic findings of a calcaneal lengthening osteotomy by comparing autologous bonegraft and HA-β-TCP graft in a group of children with hindfoot valgus deformities. The primary outcome measure is pain score (visual analog scale). We expect children who are randomized to HA-β-TCP graft to have less postoperative pain than children randomized to autologous bone graft.
Design. Prospective, randomized controlled study.
Randomization: Children who fulfill the criteria for inclusion together with their parents/guardian receive information about the project. The patients are randomized to respectively HA-ß-TCP and iliac crest bone graft.
Surgical procedure: Calcaneal lengthening osteotomy is performed between the anterior and middle facet of the subtalar joint. The corticalis of the calcaneus is bilaterally cut through. The planovalgus deformity is corrected and with a graft matching the wedged osteotomy is inserted. Tantalum balls are inserted into calcaneus on each side of the osteotomy and in cuboideum. Postoperative pain treatment consist of a tibial nerve catheter which is used the first 24 hours. Patients in whom graft is harvested from the iliac crest get local infiltration analgesics accordingly to a standardized procedure. The pain is registered by the use of a visual analog scale (VAS) a 3, 8 and 12 hours postoperative. The amounts of used analgesics are registered.
Power and significance: The primary parameter is postoperative pain score. We expect the use of artificial bone graft will reduce the VAS score from 60 mm to 30 mm. A reduction of 30 mm corresponds to a significant fall in pain intensity. With reference to a former published study on a comparable patient group we expect a standard deviation of 25 mm in the population. Therefore the number of patients in each group should be 12 in order to demonstrate a significant difference of 30 mm. We strive towards 2x15 patients in order to compensate for eventual drop-outs. We used an non-paired design with power = 80 % of p < 0.05%.
Eligibility| Ages Eligible for Study: | 5 Years to 16 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children aged between 5-16 years with symptomatic planovalgus deformity admitted to the Department of Children's Orthopaedics, Aarhus University Hospital during the period 2012 to 2016. The surgical procedure is performed in about 10 children a year.
- Pain and/or callosities.
- Informed written consent from the child custody/guardianship.
Exclusion Criteria:
- Children with soft bones (osteomalacia)
- Children with cognitive impairment
- Children with no ability to stand
Contacts and Locations| Denmark | |
| Aarhus University Hospital | Not yet recruiting |
| Aarhus, Denmark, 8000 | |
| Contact + 45 7846 4131 | |
| Contact: Polina Martinkevich, PhD-student +45 23 74 25 14 iampolina@hotmail.com | |
| Principal Investigator: Polina Martinkevich, PhD-student | |
| Study Director: | Bjarne Møller-Madsen, DMSc, Prof | Department of Children's Orthopaedics Aarhus University Hospital |
| Principal Investigator: | Polina Martinkevich, PhD-student | Department of Children's Orthopaedics Aarhus University Hospital |
| Study Chair: | Ole Rahbek, Assoc prof PhD MD | Department of Children's Orthopaedics, Aarhus University Hospital |
| Study Chair: | Martin Gottliebsen, MD PhD-stud | Department of Children's Orthopaedics, Aarhus University Hospital |
| Study Chair: | Maiken Stilling, MD, PhD | Department of Orthopaedics, Aarhus University Hospital |
| Study Chair: | Line Kjeldgaard Pedersen, MD, PhD | Department of Children's Orthopaedics, Aarhus University Hospital |
More Information
No publications provided
| Responsible Party: | University of Aarhus |
| ClinicalTrials.gov Identifier: | NCT01770574 History of Changes |
| Other Study ID Numbers: | 1-10-72-250-12, Interventional |
| Study First Received: | September 26, 2012 |
| Last Updated: | January 17, 2013 |
| Health Authority: | Denmark: Ethics Committee |
Keywords provided by University of Aarhus:
|
calcaneal lengthening |
Additional relevant MeSH terms:
|
Flatfoot Foot Deformities Musculoskeletal Diseases |
ClinicalTrials.gov processed this record on May 22, 2013